The present study indicates that in melanoma cells RGDS peptide interacts with intracellular targets, namely apoptotic caspases and survivin; identifies RGDS as a survivin-targeting molecule and indicates a novel mechanism to control cell proliferation. Here, BIRC5 is linked to melanoma.